Who is sponsoring NCT00275418?

NCT00275418 is sponsored by Bnai Zion Medical Center.

What condition does NCT00275418 study?

NCT00275418 studies Crohn's Disease.

What drugs are being tested in NCT00275418?

Interventions: beta carotene from Dunaliella algae.

What is the status of NCT00275418?

NCT00275418 is currently UNKNOWN.

Last reviewed 2006-01-10 · How we verify

Double-Blind Randomized Prospective Trial of Treatment With Natural Beta Carotene Vs. Placebo for Patients With Crohn's Disease in Remission

NCT00275418 Phase 3 UNKNOWN

Many inflammatory disorders in the body are linked to oxidative tissue damage. Anti-oxidants that are present in many natural food sources may provide protection from such damage. Beta carotene is an anti-oxidant vitamin present in many fruits and vegetables. The algae Dunaliella is particularly rich in beta carotene. In this prospective trial we want to investigate whether beta carotene from Dunaliella may prevent exacerbations of Crohn's disease.

Details

Lead sponsor	Bnai Zion Medical Center
Phase	Phase 3
Status	UNKNOWN
Enrolment	300
Start date	2002-07

Conditions

Crohn's Disease

Interventions

beta carotene from Dunaliella algae

Primary outcomes

CDAI score measured 3-monthly during treatment

Countries

Israel